Top Markets
Coin of the day
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
Rang in aandelen #35576
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aandeelprijs
$0.01851783
Laatst gesynchroniseerd: 2023-05-23
Marktkapitalisatie
$3.71M
Verandering (1 dag)
-0.04%
Verandering (1 jaar)
0.00%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)

Categorie

Dividendrendementgeschiedenis voor Tetra Bio-Pharma Inc. (TBP)
Het dividendrendement (TTM) van Tetra Bio-Pharma Inc. (aandelsymbool: TBP) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Tetra Bio-Pharma Inc. (TBP) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten